1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries

Tamburino, C.; Capranzano, P.; Gori, T.; Latib, A.; Lesiak, M.; Nef, H.; Caramanno, G.; Naber, C.; Mehilli, J.; Di Mario, C.; Sabaté, M.; Münzel, T.; Colombo, A.; Araszkiewicz, A.; Wiebe, J.; Geraci, S.; Jensen, C.; Mattesini, A.; Brugaletta, S.; Capodanno, D.

Links

ORCID

Tools

Export citation

Search in Google Scholar

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries

Journal article published in 2016 by C. Tamburino, P. Capranzano, T. Gori, A. Latib, M. Lesiak, H. Nef, G. Caramanno, C. Naber, J. Mehilli, C. Di Mario

, M. Sabaté, T. Münzel, A. Colombo, A. Araszkiewicz, J. Wiebe and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload